Eicher Motors Reports Q4 Net Profit of 1520 Crore Plans 3400 Crore Investment in New Products Tulsi Gabbard Resigns as US Intelligence Chief to Support Husband with Rare Bone Cancer Bernstein Calls American Tower AMT a Potential Opportunity at the Current Juncture China Calls for APEC Cooperation as Commerce Minister Skips Opening Over Urgent Official Business Andy Burnhams Manchester Spirit Could a Mix of Collectivism and Entrepreneurialism Reshape UK Policy OpenAI Moves Ahead in AI IPO Race Confidential Filing Expected This Week RAVE Q3 2024 Earnings Modest EPS Reported Amid Market Headwinds FNWD Q1 2026 Earnings EPS Miss Slightly as Stock Nudges Higher CVSA Q1 2026 Earnings Strong EPS Surprise Drives Optimistic Start to Fiscal Year Traws Pharma Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid PreRevenue Stage BNZI Q1 2026 Earnings Substantial EPS Miss Sends Stock Lower Smart Powerr Corp CREG Q1 2026 Earnings Narrowed Loss in a Quiet Quarter Cardlytics CDLX Edges Higher Analyzing the Recent Uptick and Key Technical Levels EPAM Systems Holds Steady Above Key Support After Modest Gain Wingstop Inc WING Holds Steady Near Middle of Range as Trading Volume Remains Moderate Sylvamo Corporation SLVM Holds Steady With Slight Decline as Support Levels Remain Intact Artius II Acquisition Rights AACBR Hold Steady at 025 as Traders Watch Key Levels Jamie Dimon Issues Challenging Message to JPMorgan Workforce XXII Q1 2026 Earnings Massive EPS Miss Amid Continued Transition Rezolute Inc RZLT Slides Amid Sector Pressure Key Levels to Watch BKD Q1 2026 Earnings Narrower Loss Disappoints Shares Edge Higher MAA Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Vertex Inc VERX Q1 2026 Earnings EPS Beat Drives Modest Share Gains Revenue Unreported BSET Q1 2026 Earnings EPS Falls Short of Estimates Amid Furniture Market Headwinds Perspective Therapeutics Inc CATX Q1 2026 Earnings EPS Beat by 17 as PreRevenue Biotech Advances Radiopharmaceutical Pipeline IQST Q4 2025 Earnings Massive EPS Miss Highlights Ongoing Challenges Genmab GMAB Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Data Unavailable